ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2026
A prospective pilot study to evaluate the impact of palliative radiotherapy in upfront inoperable/chemo unfit patients with extrahepatic biliary tract tumors.
Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Extrahepatic biliary tract cancer (BTC) group of cancers are considered as highly lethal. Patients who are unfit for definitive treatment (surgery/chemotherapy) are usually kept on best supportive care (BSC) only. Literature regarding the role of palliative radiation therapy (RT) in this patient population is limited. Thus, this study aimed to evaluate the role of palliative RT in patients with advanced-stage BTC. Materials and methods: After obtaining institutional ethics committee approval, patients who fulfilled the inclusion or exclusion criteria were included in this study. Patients were treated by palliative RT (30 Gy/10#) by 3DCRT post-PTBD insertion, if jaundice was present. Patients were assessed for response, pain, and quality of life (QoL). Results were statistically analyzed using SPSS version 22. Results: Fifteen patients were selected for analysis. The mean age of the patients was 52 years (range 41-67 years). The female-to-male ratio was 4:1. Jaundice was the primary presenting symptom in 5/15 (33.33%) of patients, whereas pain alone and in combination with jaundice was observed in 3/15 (20%) and 7/15 (46.66%), respectively. Among all assessed, 53.33% showed a partial response, 26.66% showed stable disease, and 20% showed progressive disease, while no patients had a complete response. Grade 2 toxicities were observed mainly. Statistically significant changes were seen in visual analogue scores (VAS), and QoL showed improvement post RT. Conclusions: Palliative RT seems effective in patients with advanced-stage BTC who otherwise are kept on BSC only, with minimal and manageable toxicities. Studies with a larger sample size are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.